MedTrace Logo

Somatic Health Screening for Adults in Outpatient Psychiatric Care in Denmark (SomaScreen)

NCT07518446 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2800

Last updated 2026-04-08

No results posted yet for this study

Summary

People with severe mental illness have a substantially increased risk of undiagnosed and insufficiently treated somatic disease. Somatic Screening in the Capital Region Mental Health Service in Denmark (SomaScreen) is a service-level intervention implemented in psychiatric outpatient clinics in the Capital Region of Denmark to improve the detection and follow-up of somatic disease among patients with psychotic and affective disorders.

This study evaluates whether integrating structured somatic screening into mental health services leads to improved identification and management of somatic disease compared with care as usual. Using a quasi-experimental controlled design with a matched cohort, outcomes among patients exposed to the SomaScreen intervention are compared with those of patients receiving usual care in comparable psychiatric outpatient clinics outside the Capital Region.

Conditions

  • Atrial Fibrillation (AF)
  • Heart Failure
  • Asthma (Diagnosis)
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Diabetes
  • Cancer
  • Psychiatric Patients, Serious Medical Illness

Interventions

DIAGNOSTIC_TEST

Somatic Health Screening for Adults in Outpatient Psychiatric Care in Denmark (SomaScreen)

SomaScreen is a structured somatic health screening program for adults in psychiatric outpatient care (F-ACT and OPUS clinics). Trained somatic nurses and general practitioner consultants systematically assess patients for cardiovascular disease, asthma, chronic obstructive pulmonary disease (COPD), diabetes, and cancer, and may detect other somatic conditions. Patients with identified conditions are referred to their own general practitioner for follow-up and management. The intervention is distinguished from usual care by its systematic, multi-condition screening and structured referral process.

Sponsors & Collaborators

  • Amager Hospital

    lead OTHER

Principal Investigators

  • Lene F Eplov, MD, PhD, Associate Professor · Amager Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2026-04-30
Completion
2028-10-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07518446 on ClinicalTrials.gov